Tag: Mind Cure - Page 4 - Psychedelic Alpha

Read more about the article MINDCURE Receives Unconditional Ethics Approval for its Psychedelic Integration Protocol Research Study

MINDCURE Receives Unconditional Ethics Approval for its Psychedelic Integration Protocol Research Study

Post published:March 9, 2021
Post category:Press Release

Read more about the article MINDCURE Discovers Potential Opportunity for Ibogaine-Assisted Psychotherapy to Treat Neuropathic Pain and Traumatic Brain Injury

MINDCURE Discovers Potential Opportunity for Ibogaine-Assisted Psychotherapy to Treat Neuropathic Pain and Traumatic Brain Injury

Post published:March 4, 2021
Post category:Press Release

Read more about the article MINDCURE Announces Manufacturing of Synthetic Ibogaine to be Used in Company’s Clinical Research

MINDCURE Announces Manufacturing of Synthetic Ibogaine to be Used in Company’s Clinical Research

Post published:March 3, 2021
Post category:Press Release

Read more about the article MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada’s First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin

MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada’s First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin

Post published:March 2, 2021
Post category:Press Release

Read more about the article Mind Cure Announces Addition of Global Technology Leader Robert C. Hill to Board of Directors

Mind Cure Announces Addition of Global Technology Leader Robert C. Hill to Board of Directors

Post published:February 22, 2021
Post category:Press Release

Read more about the article MINDCURE Announces Official Release of Nootropic and Adaptogen Products, Available on E-Commerce Platform

MINDCURE Announces Official Release of Nootropic and Adaptogen Products, Available on E-Commerce Platform

Post published:February 18, 2021
Post category:Press Release

Read more about the article Mind Cure Comments on Recent Promotional Activity

Mind Cure Comments on Recent Promotional Activity

Post published:February 17, 2021
Post category:Press Release

Read more about the article MINDCURE’s Proprietary Bioinformatics Platform, PsyCollage, Beta Tested and Deployed for Product Discovery and Lead Optimization

MINDCURE’s Proprietary Bioinformatics Platform, PsyCollage, Beta Tested and Deployed for Product Discovery and Lead Optimization

Post published:February 16, 2021
Post category:Press Release

Read more about the article MINDCURE Announces Listing of Warrants

MINDCURE Announces Listing of Warrants

Post published:February 11, 2021
Post category:Press Release

Read more about the article Mind Cure Announces Closing of $23 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option

Mind Cure Announces Closing of $23 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option

Post published:February 10, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.